MarketPulse

depression treatment

5 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Mental Health Clinical Trials Market Poised for 51% Growth Through 2030

Mental health clinical trials market projected to grow 51% from $3.23B (2025) to $4.89B (2030) at 8.6% CAGR, driven by digital innovation and Asia-Pacific expansion.
JNJMRKPFEABBVremote monitoringdecentralized trials
GlobeNewswire Inc.GlobeNewswire Inc.··Na

NRx Pharmaceuticals Appoints First Chief Commercial Officer Ahead of Ketamine FDA Approvals

NRx Pharmaceuticals names Glenn Tyson as inaugural Chief Commercial Officer, bolstering leadership ahead of anticipated FDA approvals for ketamine products.
NRXPNRXPWBreakthrough Therapy DesignationFast Track designation
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Two Biotech Stocks Poised to Outpace Summit Therapeutics Amid FDA Uncertainty

Summit Therapeutics faces FDA decision on ivonescimab by November 2026 amid efficacy concerns, while Axsome and Madrigal positioned for outperformance.
AXSMMDGLSMMTregulatory riskFDA approval
GlobeNewswire Inc.GlobeNewswire Inc.··Nrx Pharmaceuticals

NRx Subsidiary HOPE Therapeutics Expands with Florida Clinic Offering Rapid Depression, PTSD Care

NRx subsidiary HOPE Therapeutics opened a Palm Beach clinic offering same-day ketamine, TMS, and hyperbaric oxygen treatments for depression and PTSD, reporting 87% clinical response rates and 90% functional recovery with combined therapy.
NRXPNRXPWPTSDdepression treatment
GlobeNewswire Inc.GlobeNewswire Inc.··Sns Insider

Online Therapy Market to Hit $17.34B by 2035 as Mental Health Awareness Surges

Online therapy market projected to grow from $4.38B (2025) to $17.34B (2035) at 14.76% CAGR, driven by mental health awareness and AI-enabled telehealth platforms.
TDOCTALKTALKWmarket growthtelehealth